Admiron Life Sciences Private Limited filed a petition to initiate Corporate Insolvency Resolution Process (CIRP) under Section 10 of the Insolvency and Bankruptcy Code (IBC). The company had obtained credit facilities from State Bank of Hyderabad (now State Bank of India) and defaulted on payments. The bank had initiated actions under the SARFAESI Act to recover its dues. The petition was filed while the SARFAESI proceedings were ongoing.
Admiron Life Sciences Private Limited, incorporated on 06.12.2010, sought to initiate Corporate Insolvency Resolution Process (CIRP). The company obtained credit facilities from State Bank of Hyderabad (now State Bank of India), amounting to 39 Crores as a term loan and 20 Crores as cash credit. The company defaulted on its payments, leading the bank to initiate SARFAESI proceedings. The outstanding amount as of 29.03.2017 was Rs.66,79,80,523.00. The unsecured creditors amounted to Rs. 4,39,06,152 as of 16.06.2017. The company petition was filed under Section 10 of the IBC while SARFAESI proceedings were pending. The authorized share capital of the Corporate Applicant is 45,00,00,000 (Rupees Forty Five Crores only) divided into 45000000 (Four Crore Fifty Lakh) of Rs.
…Sign in to view the parties.
Admiron Life Sciences Private Limited was…
The Corporate Applicant obtained various credit…
Admiron Life Sciences Private Limited filed a petition to initiate Corporate Insolvency Resolution Process (CIRP) under Section 10 of the Insolvency and Bankruptcy Code (IBC). The company had obtained credit facilities from State Bank of Hyderabad (now State Bank of India) and defaulted on payments. The bank had initiated actions under the SARFAESI Act to recover its dues. The petition was filed while the SARFAESI proceedings were ongoing.
Admiron Life Sciences Private Limited, incorporated on 06.12.2010, sought to initiate Corporate Insolvency Resolution Process (CIRP). The company obtained credit facilities from State Bank of Hyderabad (now State Bank of India), amounting to 39 Crores as a term loan and 20 Crores as cash credit. The company defaulted on its payments, leading the bank to initiate SARFAESI proceedings. The outstanding amount as of 29.03.2017 was Rs.66,79,80,523.00. The unsecured creditors amounted to Rs. 4,39,06,152 as of 16.06.2017. The company petition was filed under Section 10 of the IBC while SARFAESI proceedings were pending. The authorized share capital of the Corporate Applicant is 45,00,00,000 (Rupees Forty Five Crores only) divided into 45000000 (Four Crore Fifty Lakh) of Rs.
…Admiron Life Sciences Private Limited was…
The Corporate Applicant obtained various credit…